CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression

Abstract

Psychotic major depression (PMD) is found to be a relatively common psychiatric condition that affects up to nearly 20% of patients with major depression. Previous studies by our group have shown rapid reversal of psychotic symptoms in some PMD patients treated with mifepristone, in addition to restoring a more normal afternoon cortisol release. The rationale for treating patients with PMD with a glucocorticosteroid receptor antagonist is further discussed. In total, 30 patients with PMD were treated with either 600 mg/day mifepristone or placebo for 8 days in a randomized double-blind manner. The Hamilton Depression Rating Scale (HDRS) and the Brief Psychiatric Rating Scale (BPRS) were administered at baseline and again after 8 days of treatment. Cortisol and ACTH were measured hourly from 1800 to 0900 at baseline and after 8 days of treatment. Significantly, more patients in the mifepristone group (seven of 15) showed a 50% or greater decline on the BPRS positive symptom subscale, an index of psychotic symptoms, as compared to the placebo group (two of 15). Patients who received mifepristone had lower HDRS and BPRS scores at study completion compared to those who received placebo, but these differences were not statistically significant. In addition, mifepristone significantly elevated cortisol and ACTH levels and steepened ascending slopes from 1800 to 0100 and from 0100 to 0900 as compared to placebo. Clinical and biological effects of mifepristone were comparable among males and females. Age was found to significantly and positively correlate with changes in cortisol and ACTH. These results suggest that short-term use of mifepristone may be effective in the treatment of PMD and may re-regulate the HPA axis. Additional blinded studies are warranted.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1300884

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 1

  1. First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Structured Clinical Interview for DSM IV-TR Axis I Disorders—Patient Edition (SCID-I/P, 2/2001 revision). American Psychiatric Press, Inc.: Washington, DC.

Cited by

See all 204

Metadata

Authors
Flores, B. H., Kenna, H., Keller, J., Solvason, H. B., & Schatzberg, A. F.
Affiliations
  • Stanford University (US)
  • Stanford Medicine (US)
Corresponding author
Flores, Benjamin H
Venue
Neuropsychopharmacology
Published
2005-09-14
Volume
31
Issue
3
Pages
628-636
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2081535802
Cited by
203
References
41
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 12 · 2017: 9 · 2016: 9 · 2015: 10 · 2014: 12 · 2013: 13 · 2012: 11
FWCI
11.70
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (MH50604)
  • National Institute of Mental Health (R0-1MH50604, MH-47573, R01MH050604, R01 MH 47573, R01MH047573, T32MH019938)
  • National Center for Research Resources (M01RR000070)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
mifepristone, psychotic depression, glucocorticoid receptor antagonist, hypothalamic-pituitary-adrenal axis, cortisol, ACTH, depression treatment
MeSH terms
Adrenocorticotropic Hormone, Adult, Major Depressive Disorder, Depressive Disorder, Major, Double-Blind Method, Female, Hormone Antagonists, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Psychiatric Status Rating Scales, Receptors, Glucocorticoid, Sex Characteristics, Mifepristone, Linear Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression. https://app.cochat.ai/papers/10.1038/sj.npp.1300884
The paper
Flores, B. H., Kenna, H., Keller, J., Solvason, H. B., & Schatzberg, A. F. (2006). Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1300884

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.